Bloomberg Law
April 12, 2016, 8:52 PM UTC

Pfizer Faces Revived Shareholder Suit Over Celebrex, Bextra

Bloomberg Media

By Christie Smythe, Bloomberg News

Pfizer Inc. must face a shareholders’ lawsuit accusing the company of misrepresenting risks associated with the arthritis drugs Celebrex and Bextra, according to a federal appeals court.

The class action alleged Pfizer officials hid information about studies that suggested use of the drugs may result in increased risks of heart attacks and strokes. After being litigated for about a decade, the case might go before a jury now that it has been sent back to a lower court.

U.S. District Judge Laura Taylor Swain in Manhattan had thrown out testimony from the investors’ expert on the ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.